Summary AVEO Pharmaceuticals Inc (AVEO) is a biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of various types of cancers.Its proprietary platform delivers insights into cancer and related diseases.
AVEO develops its lead candidate tivozanib in North America as a treatment for renal cell carcinoma and other cancers.The company has strategic partnerships with EUSA, Novartis, Pharmstandard Group, Ophthotech Corporation, Biodesix Kyowa Hakko Kirin; Astellas Pharma, Biogen Idec International GmbH and others.
AVEO is headquartered in Cambridge, Massachusetts, the US.
AVEO Pharmaceuticals Inc (AVEO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• Dec 2020
Major players in the enzymes market are Sanofi, AbbVie Inc., Alexion Pharmaceuticals Inc, Horizon Pharma, Allergan plc, Pfizer Inc., Vivus, Digestive Care, Leadiant Biosciences and Roche Holdings AG. The global enzymes market is expected to decline from $7.98 billion in 2019 to $7.81 billion in 2020 at a compound annual growth rate...
The Europe medical cyclotron market is expected to reach US$ 59.50 million by 2027 from US$ 47.04 million in 2019, it is estimated to grow at a CAGR of 3.1% from 2020 to 2027. The growth of the market is attributed to key driving factors such as increasing prevalence of cancer and growing inclination toward nuclear scans for accurate diagnosis....
Global Pharmaceutical Partnering Terms and Agreements 2017 to 2021 report provides a detailed understanding and analysis of how and why companies enter Pharmaceutical partnering deals. This report provides details of the latest Pharmaceutical agreements announced in the life sciences since 2017. The report takes...
120 pages •
By Infiniti Research Limited
• Feb 2021
Global Marine Pharmaceuticals Market 2021-2025 The analyst has been monitoring the marine pharmaceuticals market and it is poised to grow by $ 1.43 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. Our report on marine pharmaceuticals market provides a holistic analysis, market size and forecast,...
The Global Data Historian Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include increasing demand for consolidated data for process and performance improvement, growing need for industrial 360...
120 pages •
By Infiniti Research Limited
• Jan 2021
Global Homogenizers Market 2021-2025
The analyst has been monitoring the homogenizers market and it is poised to grow by $ 322.30 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period. Our report on homogenizers market provides a holistic analysis, market size and forecast, trends, growth drivers,...
The global flow imaging microscopy market size is projected to reach USD 45 million by 2025 from USD 32 million in 2020, at a CAGR of 7.4%. The growth of the market is attributed to increasing investment in the field of nanotechnology, growing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
Healthcare
Pharmaceutical
Therapy
Endocrine Disease
Nutrition
Blood Disease
E-Commerce
Heart Failure
World
Anemia Prevalence
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.